<VariationArchive VariationID="1879066" VariationName="NC_000017.11:g.47296304_47307500del" VariationType="Deletion" Accession="VCV001879066" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-01-21" MostRecentSubmission="2023-01-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1935814" VariationID="1879066">
      <GeneList>
        <Gene Symbol="EFCAB13-DT" FullName="EFCAB13 divergent transcript" GeneID="102724508" HGNC_ID="HGNC:55338" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47303443" stop="47323901" display_start="47303443" display_stop="47323901" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="ITGB3" FullName="integrin subunit beta 3" GeneID="3690" HGNC_ID="HGNC:6156" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47253827" stop="47313743" display_start="47253827" display_stop="47313743" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45331207" stop="45390076" display_start="45331207" display_stop="45390076" Strand="+" />
          </Location>
          <OMIM>173470</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000017.11:g.47296304_47307500del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47296304" stop="47307500" display_start="47296304" display_stop="47307500" variantLength="11197" />
      </Location>
      <OtherNameList>
        <Name>ITGB3, 11.2-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.47296304_47307500del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.47296304_47307500del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.11:g.47296304_47307500del AND Glanzmann thrombasthenia" Accession="RCV002511567" Version="2">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-01-21" MostRecentSubmission="2023-01-21">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/aaf92a4c-d017-438c-906b-ba8c494b2bc3</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5507974" SubmissionDate="2023-01-17" DateLastUpdated="2023-01-21" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="aaf92a4c-d017-438c-906b-ba8c494b2bc3" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002820967" DateUpdated="2023-01-21" DateCreated="2023-01-21" Type="SCV" Version="1" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-07">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/aaf92a4c-d017-438c-906b-ba8c494b2bc3</URL>
          </Citation>
          <Comment>The 11.2kb deletion in ITGB3 (NC_000017.11:g.47296303_47307499del; NM_000212.3:c.1691-3005_2162del) begins in intron 10, removing the splice acceptor site in intron 10 through c.2162 in exon 14, leading to the skipping of exons 11-14, which is 26% of the protein (as confirmed in patient cDNA). This is predicted to cause a frameshift with a premature stop codon in exon 15/15 and truncation of the last 2% of the protein. Affected exons 14 and 15 include the transmembrane and cytoplasmic domains of β3 which are critical regions for protein function (PVS1_strong). This variant is absent from gnomAD SVs v2.1 (PM2_Supporting). At least 1 homozygote and 2 compound heterozygotes, both with the maternal pathogenic c.2031_2041del and paternal 11.2 Kb deletion (c.1691-3005_2162del) variants have been identified in PMID: 9160670 (PM3_strong). Families 1-3 of PMID: 9160670 each have two affected individuals with consistent biallelic variants (PP1). At least one patient (Patient 4 in PMID: 30078718) with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia (PP4_moderate). Additionally, αIIbβ3 surface expression was absent as measured by flow cytometry. In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1_strong, PP1, PP4_moderate, PM2_supporting, PM3_strong. (VCEP specifications version 2; date of approval 01/18/2022).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2-1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/mac6zhy2/clingen_platelet_acmg_specifications_v2-1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>ITGB3, 11.2-KB DEL</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.47296304_47307500del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12541646</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5507974" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

